Showing results (1-10 of 306) with videos related to

Sort By:
Pageof 31
Cells|August 9, 2024
Enzyme Is the Name-Adapter Is the GameMichael Huber, Tilman Brummer
Methods in Molecular Biology (Clifton, N.J.)|May 18, 2004
B-cell signal transduction: tyrosine phosphorylation, kinase activity, and calcium mobilizationTilman Brummer, Winfried Elis, Michael Reth, et al.
European Journal of Immunology|December 8, 2004
Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptorsSusana Minguet, Michael Huber, Lisa Rosenkranz, et al.
Oncogene|April 10, 2020
RAF kinase dimerization: implications for drug discovery and clinical outcomesTilman Brummer, Campbell McInnes
Critical Reviews in Oncogenesis|April 5, 2012
Aberrant B-Raf signaling in human cancer -- 10 years from bench to bedsideMichael Röring, Tilman Brummer
Molecular & Cellular Oncology|June 17, 2016
BRAF inhibitors in colorectal cancer: Toward a differentiation therapy?Ricarda Herr, Tilman Brummer
Blood|July 19, 2023
The role of the MDM2/p53 axis in antitumor immune responsesTilman Brummer, Robert Zeiser
Methods in Molecular Biology (Clifton, N.J.)|September 2, 2016
Quantitative Proteomics Analysis of Leukemia CellsSebastian Halbach, Jörn Dengjel, Tilman Brummer
The FEBS Journal|October 2, 2010
Docking proteinsTilman Brummer, Carsten Schmitz-Peiffer, Roger J Daly
Genomics Data|October 21, 2015
Global gene expression profiling analysis reveals reduction of stemness after B-RAF inhibition in colorectal cancer cell linesMelanie Boerries, Ricarda Herr, Tilman Brummer, et al.
Pageof 31